Stock Ratings / Health Care / MDWD / earnings

NAGE (63) GLAS (25) ACB (58) USNA (61) ⌘ Pro Terminal →

MediWound Ltd. (MDWD) Next Earnings Date & Expected ±9.2% Move

$13.86 +2.21% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $13.89

MediWound Ltd. (MDWD) carries a Roarable Rating of C- (Hold) with 60/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 60/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.4% avg 90D alpha vs SPY) →

ROARABLE C- • HOLD / WATCH Cap $178.9M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $13.89 (+0.21%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0.1% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 60/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.4% avg 90D alpha vs SPY • 53.5% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C-

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ · Rk B-

Each axis scored 0–20

12M PRICE TARGET CONE+0.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MDWD)Realized 20D OHLCV Swing Band: ±9.2%

Deterministic 5-Pillar Attribution (60/100 Composite)

🔍 WHY MDWD SCORES 60/100 (C-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+15/20 pts (25% of score)

FRED Regime × Technicals: 26% of 52W Range • RSI-14 at 55.1 (BULLISH MOMENTUM)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (22% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution9/20 pts (-11 pt drag)

Disciplined Float (-0.40% YoY Shares) & executive Form 4 sales trim 11 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$12.54-5.5% Next Q

Q2 (-2Q)

Grade C$11.85+1.3% Next Q

Q3 (-1Q)

Grade C$12.00+15.5% Next Q

Current

Grade C-$13.86+0.4% Hist 90D α

Trajectory: C- (52) → C- (60)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the MDWD Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 60/100 (C-) score, MDWD faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Company executives have done more routine share selling than personal cash buying lately.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Disciplined Float (-0.40% YoY Shares) — any gross margin slip below 49.5% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($13.06) or 200D SMA ($15.24) invalidates the momentum regime and cuts Target Base ($13.98) toward Bear Floor ($10.90).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MDWD• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MDWD Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”

YES 60%NO 40%Trade / Inspect Odds →

NEXT EST. WINDOW: Upcoming Quarter (~28 DAYS)

Historical OHLCV Volatility ±9.2% Swing Band

±$1.28 Expected Swing

MODEL EARNINGS SETUP GAUGE

MDWD Quantitative Pre-Earnings Setup: 60/100

Trailing EPS: $4.25 • YoY Revenue Growth: 12.4%

Model Bullish Setup (60/100)Model Risk Weight (40/100)

Derived deterministically from RQD cash-flow quality, SEC accrual safety, and institutional flow (not a community poll).

LOG YOUR PERSONAL PRE-EARNINGS STANCE (SAVED LOCALLY IN BROWSER):

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating MDWD & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on MDWD
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MDWD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -16.00%▲ RESISTANCE BREAKOUT

2026-10-30O $13.94H $13.94L $13.24C $13.86VOL 110.1K

RES: $13.61SUP: $11.73SMA50: $13.06SMA200: $15.24

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MDWD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MDWD Butterfly Map → + Track MDWD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MDWD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MDWD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MDWD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MDWD)

Health Care Rank #204 of 1016 ⚔️ NAGE vs MDWD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MDWD vs. NAGE, GLAS, ACB, USNA)

Industry: Medicinal Chemicals and Botanical Products (24 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, MediWound Ltd. (MDWD) ranks #204 by composite RQD confidence (60/100, grade C-) and #591 by equity capitalization ($178.9M). Within this direct 5-issuer industry benchmark cohort, NAGE leads on earnings valuation at 11.4x trailing P/E, while NAGE leads on capital efficiency and profitability with 16.8% ROIC and 64.3% gross margin. NAGE currently holds the highest overall quantitative score in the immediate peer group at 63/100 (C) compared with MDWD at 60/100 (C-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MDWD ACTIVE MediWound Ltd.	C-	60/100	—	—	—	+2.21%	$178.9M	Benchmark Subject
NAGE Niagen Bioscience Inc.	C	63/100	11.4x	64.3%	16.8%	-1.57%	$197.8M	/nage-vs-mdwd →
GLAS Glass House Brands Inc. Subordinate Voting Shares	E	25/100	—	42.3%	-9.2%	+1.33%	$200.6M	/glas-vs-mdwd →
ACB Aurora Cannabis Inc.	D+	58/100	—	—	—	0.00%	$252.8M	/acb-vs-mdwd →
USNA USANA Health Sciences Inc.	C-	61/100	24.6x	78.3%	7.9%	-1.91%	$265.0M	/usna-vs-mdwd →

2. MDWD Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

MediWound Ltd. (MDWD) operates in Medicinal Chemicals and Botanical Products (Health Care) with an equity capitalization of $178.9M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. MDWD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MDWD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, MediWound Ltd. (NASDAQ: MDWD) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 60/100 at a spot price of $13.86 (+2.21% 1D, market cap $178.9M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 11/20, Executive Insider Alignment 13/20, FRED Macro Regime Fit 15/20, and SEC Balance-Sheet Forensics 9/20. Across 1016 tracked Health Care issuers, MDWD ranks #204 in composite RQD confidence.

How does MDWD compare to NAGE and GLAS in the Health Care sector?

Within the Health Care sector (Medicinal Chemicals and Botanical Products), MDWD carries a Roarable C- (60/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, NAGE (Niagen Bioscience Inc.) holds a C grade (63/100 RQD, P/E 11.4x, ROIC 16.8%, cap $197.8M) and GLAS (Glass House Brands Inc. Subordinate Voting Shares) posts a E grade (25/100 RQD, P/E N/A, ROIC -9.2%, cap $200.6M). Among the 5-stock peer group, NAGE leads on earnings multiple (11.4x) while NAGE leads on capital efficiency (16.8% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MDWD?

For MediWound Ltd. (MDWD), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity. and sector rank #204 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately. and implied 5-year growth hurdle of 8.0%/yr. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MDWD trading relative to its 50-day, 200-day, and 52-week technical levels?

MDWD last traded at $13.86 (+2.21% on volume of 154,410 shares), positioning the stock +6.13% above its 50-day simple moving average ($13.06) and -9.06% below its 200-day simple moving average ($15.24). Across its 52-week range of $11.80 to $19.70, MDWD sits at the 26.1% percentile with a 14-day RSI of 55.1 (BULLISH MOMENTUM) and an implied next-earnings move of ±9.2% ($12.58 to $15.14).

MDWD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

When is MDWD's next earnings date?

Based on SEC filing cadence, MediWound Ltd. (MDWD)'s next quarterly reporting window is estimated around Upcoming Quarter.

How much is MDWD stock expected to move on earnings?

Volatility modeling currently projects a ±9.2% event move for MDWD, spanning a range between $12.58 and $15.14.

Direct Sub-Reports: MDWD RQD Cockpit MDWD 12M Forecast MDWD Earnings & Move MDWD Dividends & DRIP MDWD Insiders & 13F MDWD Whale Options MDWD Profit Sankey MDWD News & Why